Peritoneum as the first-line of defense in carcinomatosis

Journal of Surgical Oncology

Volumn 95, Issue 2, 2007, Pages 93-96

  Sugarbaker, Paul H ^a,b  

^a WASHINGTON CANCER INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHOLIPID;

ANTIGEN PRESENTATION; BASEMENT MEMBRANE; CANCER CELL; CANCER GROWTH; CANCER LOCALIZATION; CARCINOGENESIS; CARCINOMATOSIS; CONNECTIVE TISSUE; CYTOREDUCTIVE SURGERY; EARLY DIAGNOSIS; EDITORIAL; HUMAN; INFLAMMATION; MESENTERY; MESOTHELIUM CELL; PERITONEAL CAVITY; PERITONEAL FLUID; PERITONEUM; PERITONEUM CANCER; PRIORITY JOURNAL; SURGICAL TECHNIQUE;

EID: 33846912272     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20676     Document Type: Editorial

References (5)

1. Shimotsuma M, Shields JW, Simpson-Morgan MW, et al.: Morphophysiological function and role of omental milky spots as omentum-associated lymphoid tissue (OALT) in the peritoneal cavity. Lymphology 1993;26:90-101.
2. Yonemura Y: Peritoneal Dissemination - Molecular Mechanisms and the Latest Therapy. Kanazawa, Japan: Maeda Shoten C., Ltd.; 1998. pp 18-24.
3. Sugarbaker PH, Averbach AM: Krukenberg syndrome as a natural manifestation of tumor cell entrapment. In: Sugarbaker PH, editor. Peritoneal Carcinomatosis: Principles of Management. Boston: Kluwer Academic Publishers; 1996. pp 163-191.
4. Sugarbaker TA, Chang D, Koslowe P, et al.: Pathobiology of peritoneal carcinomatosis from ovarian malignancy. In: Sugarbaker PH, editor. Peritoneal Carcinomatosis: Principles of Management. Boston: Kluwer Academic Publishers; 1996. pp 63-74.
5. Sugarbaker PH, Alderman R, Edwards G, et al.: Prospective morbidity and mortality assessment of cytoreductive surgery plus perioperative intraperitoneal chemotherapy to treat peritoneal dissemination of appendiceal mucinous malignancy. Ann Surg Oncol 2006 March 10 [Epub ahead of print].